We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
206 result(s) found, displaying 151 to 160
-
Cancellation by sponsorRequested by Takeda Pharmaceuticals Australia Pty Ltd
-
Cancellation by sponsorRequested by Takeda Pharmaceuticals Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIXUBIS nonacog gamma (rch) 500 IU powder and solvent for solution for injection glass vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIXUBIS nonacog gamma (rch) 1000 IU powder and solvent for solution for injection glass vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIXUBIS nonacog gamma (rch) 250 IU powder and solvent for solution for injection glass vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIXUBIS nonacog gamma (rch) 2000 IU powder and solvent for solution for injection glass vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIXUBIS nonacog gamma (rch) 3000 IU powder and solvent for solution for injection glass vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NESINA MET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NESINA MET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack.